PHILADELPHIA -- More than 90 percent of humans have antibodies to the Epstein Barr virus. Best known for causing mononucleosis, or “the kissing disease,” the virus has also been implicated in more serious conditions, including Hodgkin’s, non-Hodgkin’s and Burkitt’s lymphomas. Yet little is known about exactly how EBV triggers these diseases.
Seema Bhatnagar of the Perelman School of Medicine comments on leading a study about how toenhance stress resilience in military personnel.
Penn and Wistar researchers are featured for their work to control HIV without antiviral drugs.
Arthur Caplan of the Perelman School of Medicine comments on a report of an organ-harvesting facility in China.
Researchers from the Perelman School of Medicine at the University of Pennsylvania report this month in Cancer Research a universal approach to personalized cancer therapy based on T cells. It is the first time a system for making an adaptable, engineered T-cell to attack specific tumor types has been proposed, depending on which abnormal proteins, called antigens, are expressed by individual patients’ tumor cells.
Aggressive treatment for severe traumatic brain injuries costs more than routine care, yet yields significantly better outcomes, improved quality of life, and lower long term care costs, according to a new study by researchers in the Perelman School of Medicine at the University of Pennsylvania. For example, in 20 year old traumatic brain injury survivor, aggressive care leads to significantly improved outcomes and costs nearly $100,000 less compared to routine care.